In this study, we demonstrated that leflunomide treatment effectively decreased atherosclerotic plaque area both in the en-face aortas and aortic sinus and had a strong anti-atherosclerosis effect in WD-fed ApoE-/- mice through regulating lipid metabolism and vascular function. The gene discussed is APOE; the disease is atherosclerosis.